Edition:
United Kingdom

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

12.20USD
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
$12.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
290,081
52-wk High
$24.45
52-wk Low
$12.10

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Arnold Oronsky

77 2006 Independent Chairman of the Board

Eddie Gray

59 2013 Chief Executive Officer, Director

Michael Ostrach

66 2016 Chief Financial Officer, Senior Vice President, Chief Business Officer

Robert Coffman

71 2014 Senior Vice President, Chief Scientific Officer

Robert Janssen

64 2018 Chief Medical Officer, Senior Vice President - Clinical Development, Medical and Regulatory Affairs